PubRank

N L Letvin

Author PubWeight™ 359.93‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 1999 21.24
2 Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science 2000 9.92
3 Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. Science 1985 9.27
4 Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science 1999 7.66
5 The isolation and characterization of the human suppressor inducer T cell subset. J Immunol 1985 6.69
6 Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III. Science 1985 6.02
7 Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease. Lancet 1998 5.46
8 The isolation and characterization of the human helper inducer T cell subset. J Immunol 1985 5.21
9 A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys. J Virol 1996 5.06
10 A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes. J Exp Med 1989 4.16
11 ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency. J Virol 2002 4.11
12 Infection of cynomolgus monkeys with a chimeric HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoproteins. J Acquir Immune Defic Syndr 1992 3.94
13 Serologic identification and characterization of a macaque T-lymphotropic retrovirus closely related to HTLV-III. Science 1985 3.74
14 Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques. J Virol 1994 3.71
15 An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys. J Virol 1996 3.51
16 Analysis of Gag-specific cytotoxic T lymphocytes in simian immunodeficiency virus-infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex. J Exp Med 1998 3.35
17 Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys. J Virol 1993 3.27
18 Long-term persistent infection of macaque monkeys with the simian immunodeficiency virus. J Gen Virol 1987 3.18
19 Emergence of CTL coincides with clearance of virus during primary simian immunodeficiency virus infection in rhesus monkeys. J Immunol 1999 3.17
20 Vaccine protection against simian immunodeficiency virus infection. Proc Natl Acad Sci U S A 1989 3.13
21 In vitro growth characteristics of simian T-lymphotropic virus type III. Proc Natl Acad Sci U S A 1985 2.90
22 Definition of an epitope and MHC class I molecule recognized by gag-specific cytotoxic T lymphocytes in SIVmac-infected rhesus monkeys. J Immunol 1991 2.77
23 Suppression of simian immunodeficiency virus replication in vitro by CD8+ lymphocytes. J Immunol 1988 2.68
24 Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination. J Virol 2001 2.66
25 Nononcogenic deletion mutants of herpesvirus saimiri are defective for in vitro immortalization. J Virol 1986 2.52
26 Characterization of molecularly cloned simian-human immunodeficiency viruses causing rapid CD4+ lymphocyte depletion in rhesus monkeys. J Virol 1997 2.28
27 Persistent infection of macaques with simian-human immunodeficiency viruses. J Virol 1995 2.22
28 A new type D retrovirus isolated from macaques with an immunodeficiency syndrome. Science 1984 2.22
29 Acquired immunodeficiency syndrome in a colony of macaque monkeys. Proc Natl Acad Sci U S A 1983 2.17
30 Immunization with a modified vaccinia virus expressing simian immunodeficiency virus (SIV) Gag-Pol primes for an anamnestic Gag-specific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challenge. J Virol 2000 2.15
31 1F7, a novel cell surface molecule, involved in helper function of CD4 cells. J Immunol 1989 2.04
32 Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection. J Virol 2000 2.01
33 JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy. Neurology 1999 1.97
34 Prevalence of antibodies to 3 retroviruses in a captive colony of macaque monkeys. Int J Cancer 1988 1.96
35 The gag-specific cytotoxic T lymphocytes in rhesus monkeys infected with the simian immunodeficiency virus of macaques. J Immunol 1990 1.87
36 Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile. Immunol Lett 1996 1.87
37 Recombinant modified vaccinia virus Ankara-simian immunodeficiency virus gag pol elicits cytotoxic T lymphocytes in rhesus monkeys detected by a major histocompatibility complex class I/peptide tetramer. Proc Natl Acad Sci U S A 1998 1.74
38 Simian immunodeficiency virus DNA vaccine trial in macaques. J Virol 1996 1.71
39 T lymphocyte surface antigens in primates. Eur J Immunol 1983 1.68
40 Evolution of the MHC class I genes of a New World primate from ancestral homologues of human non-classical genes. Nature 1990 1.68
41 Cytotoxic T lymphocytes do not appear to select for mutations in an immunodominant epitope of simian immunodeficiency virus gag. J Immunol 1992 1.65
42 T cell receptor V beta repertoire in an acute infection of rhesus monkeys with simian immunodeficiency viruses and a chimeric simian-human immunodeficiency virus. J Exp Med 1995 1.61
43 CD8+CD4- lymphocyte lines can harbor the AIDS virus in vitro. J Immunol 1989 1.60
44 The envelope glycoprotein ectodomains determine the efficiency of CD4+ T lymphocyte depletion in simian-human immunodeficiency virus-infected macaques. J Exp Med 1998 1.59
45 Neutralizing antibodies in sera from macaques infected with chimeric simian-human immunodeficiency virus containing the envelope glycoproteins of either a laboratory-adapted variant or a primary isolate of human immunodeficiency virus type 1. J Virol 1998 1.57
46 Use of major histocompatibility complex class I/peptide/beta2M tetramers to quantitate CD8(+) cytotoxic T lymphocytes specific for dominant and nondominant viral epitopes in simian-human immunodeficiency virus-infected rhesus monkeys. J Virol 1999 1.56
47 Effect of recombinant soluble CD4 in rhesus monkeys infected with simian immunodeficiency virus of macaques. Nature 1989 1.55
48 Characterization of primary isolate-like variants of simian-human immunodeficiency virus. J Virol 1999 1.55
49 Augmentation of fetal-hemoglobin production in anemic monkeys by hydroxyurea. N Engl J Med 1984 1.54
50 Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. J Clin Invest 1995 1.54
51 Lymphadenopathy in macaques experimentally infected with the simian immunodeficiency virus (SIV). Am J Pathol 1987 1.54
52 Recombinant virus vaccine-induced SIV-specific CD8+ cytotoxic T lymphocytes. Science 1991 1.52
53 Use of human leukocyte-specific monoclonal antibodies for clinically immunophenotyping lymphocytes of rhesus monkeys. Cytometry 1994 1.51
54 Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys. Proc Natl Acad Sci U S A 2000 1.50
55 Characterization of simian-human immunodeficiency virus envelope glycoprotein epitopes recognized by neutralizing antibodies from infected monkeys. J Virol 1998 1.49
56 A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody. J Clin Invest 1987 1.46
57 Elicitation of high-frequency cytotoxic T-lymphocyte responses against both dominant and subdominant simian-human immunodeficiency virus epitopes by DNA vaccination of rhesus monkeys. J Virol 2001 1.45
58 Conservation of myeloid surface antigens on primate granulocytes. Blood 1983 1.44
59 Syrian hamsters express diverse MHC class I gene products. J Immunol 1990 1.44
60 Simian immunodeficiency virus evades a dominant epitope-specific cytotoxic T lymphocyte response through a mutation resulting in the accelerated dissociation of viral peptide and MHC class I. J Immunol 2000 1.43
61 Comparative analysis of cytotoxic T lymphocytes in lymph nodes and peripheral blood of simian immunodeficiency virus-infected rhesus monkeys. J Virol 1999 1.43
62 Humoral immune responses to T cell tropic retrovirus simian T lymphotropic virus type III in monkeys with experimentally induced acquired immune deficiency-like syndrome. J Clin Invest 1986 1.43
63 Histopathologic changes in macaques with an acquired immunodeficiency syndrome (AIDS). Am J Pathol 1983 1.39
64 Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis. Analysis with anti-2H4 monoclonal antibody. N Engl J Med 1987 1.38
65 Changes in human immunodeficiency virus type 1 envelope glycoproteins responsible for the pathogenicity of a multiply passaged simian-human immunodeficiency virus (SHIV-HXBc2). J Virol 1999 1.36
66 A novel epitope of the LFA-1 antigen which can distinguish killer effector and suppressor cells in human CD8 cells. Nature 1988 1.36
67 Two distinct lymphocyte populations mediate simian immunodeficiency virus envelope-specific target cell lysis. J Immunol 1990 1.36
68 JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy. J Virol 2001 1.35
69 Immunophenotypic characterization of the cutaneous exanthem of SIV-infected rhesus monkeys. Apposition of degenerative Langerhans cells and cytotoxic lymphocytes during the development of acquired immunodeficiency syndrome. Am J Pathol 1987 1.32
70 Detection of JC virus-specific cytotoxic T lymphocytes in healthy individuals. J Virol 2004 1.32
71 Major histocompatibility complex class I molecules of nonhuman primates. Eur J Immunol 1988 1.32
72 Augmentation and suppression of immune responses to an HIV-1 DNA vaccine by plasmid cytokine/Ig administration. J Immunol 1998 1.32
73 Diversity of the killer cell Ig-like receptors of rhesus monkeys. J Immunol 2001 1.31
74 Immunization with recombinant BCG-SIV elicits SIV-specific cytotoxic T lymphocytes in rhesus monkeys. J Immunol 1993 1.30
75 Clinicopathologic characterization of canine juvenile cellulitis. Vet Pathol 1989 1.30
76 Membrane-fusing capacity of the human immunodeficiency virus envelope proteins determines the efficiency of CD+ T-cell depletion in macaques infected by a simian-human immunodeficiency virus. J Virol 2001 1.29
77 Comparative biology of natural and experimental SIVmac infection in macaque monkeys: a review. J Med Primatol 1990 1.29
78 Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys. J Virol 1996 1.29
79 Cytokine requirements for induction of systemic and mucosal CTL after nasal immunization. J Immunol 2001 1.28
80 Studies of cloned simian immunodeficiency virus-specific T lymphocytes. gag-specific cytotoxic T lymphocytes exhibit a restricted epitope specificity. J Immunol 1990 1.28
81 Cytotoxic effector cell granules recognized by the monoclonal antibody TIA-1 are present in CD8+ lymphocytes in lymph nodes of human immunodeficiency virus-1-infected patients. Am J Pathol 1993 1.27
82 Immunologic effects of whole-body ultraviolet irradiation: selective defect in splenic adherent cell function in vitro. Proc Natl Acad Sci U S A 1980 1.26
83 Morphologic changes in lymph nodes of macaques with an immunodeficiency syndrome. Lab Invest 1984 1.26
84 JCV-specific cellular immune response correlates with a favorable clinical outcome in HIV-infected individuals with progressive multifocal leukoencephalopathy. J Neurovirol 2001 1.24
85 Vaccination of rhesus monkeys with synthetic peptide in a fusogenic proteoliposome elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes. J Exp Med 1992 1.23
86 The role of the 2H4 molecule in the generation of suppressor function in Con A-activated T cells. J Immunol 1986 1.22
87 Simian immunodeficiency virus inhibits bone marrow hematopoietic progenitor cell growth. J Virol 1990 1.21
88 Simian immunodeficiency virus (SIV)-specific cytotoxic T lymphocytes in gastrointestinal tissues of chronically SIV-infected rhesus monkeys. Blood 2001 1.21
89 In healthy primates, circulating autoreactive T cells mediate autoimmune disease. J Clin Invest 1994 1.20
90 Transmission of naturally occurring lymphoma in macaque monkeys. Proc Natl Acad Sci U S A 1983 1.20
91 Immune biology of macaque lymphocyte populations during mycobacterial infection. Clin Exp Immunol 2003 1.20
92 Molecular cloning of orangutan and gibbon MHC class I cDNA. The HLA-A and -B loci diverged over 30 million years ago. J Immunol 1992 1.20
93 Animal models for acquired immunodeficiency syndrome. Rev Infect Dis 1987 1.19
94 Conserved T-cell receptor repertoire in simian immunodeficiency virus-infected rhesus monkeys. J Immunol 1993 1.19
95 Synthetic peptide in mineral oil adjuvant elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes in rhesus monkeys. J Immunol 1993 1.19
96 Experimental transmission of macaque AIDS by means of inoculation of macaque lymphoma tissue. Lancet 1983 1.19
97 A naturally occurring bone-marrow-chimeric primate. I. Integrity of its immune system. Transplantation 1985 1.18
98 Human immunodeficiency virus type 1 envelope glycoprotein-specific cytotoxic T lymphocytes in simian-human immunodeficiency virus-infected rhesus monkeys. Virology 1995 1.17
99 The cellular basis for the induction of antigen-specific T8 suppressor cells. Eur J Immunol 1986 1.17
100 Antiretroviral agents restore Mycobacterium-specific T-cell immune responses and facilitate controlling a fatal tuberculosis-like disease in Macaques coinfected with simian immunodeficiency virus and Mycobacterium bovis BCG. J Virol 2001 1.17
101 Definition of human immunodeficiency virus type 1 gp120 and gp41 cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I alleles in simian-human immunodeficiency virus-infected rhesus monkeys. J Virol 1996 1.15
102 Herpesvirus saimiri strain 11 immortalizes a restricted marmoset T8 lymphocyte subpopulation in vitro. J Exp Med 1986 1.15
103 Lymphoma in macaques: association with virus of human T lymphotrophic family. Science 1984 1.15
104 Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: a new model for multiple sclerosis. Ann Neurol 1995 1.14
105 Antigenic stimulation by BCG vaccine as an in vivo driving force for SIV replication and dissemination. Nat Med 1998 1.14
106 2H1--a novel antigen involved in T lymphocyte triggering. J Immunol 1988 1.13
107 Vaccine-elicited immune responses prevent clinical AIDS in SHIV(89.6P)-infected rhesus monkeys. Immunol Lett 2001 1.13
108 Expression of the CD8alpha beta-heterodimer on CD8(+) T lymphocytes in peripheral blood lymphocytes of human immunodeficiency virus- and human immunodeficiency virus+ individuals. Blood 1998 1.13
109 B-lymphocyte responses to trinitrophenyl-conjugated Ficoll: requirement for T lymphocytes and Ia-bearing adherent cells. Proc Natl Acad Sci U S A 1981 1.12
110 A MHC class I B locus allele-restricted simian immunodeficiency virus envelope CTL epitope in rhesus monkeys. J Immunol 1995 1.12
111 In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. In vivo stability of disulfide-linked immunotoxin conjugates. J Clin Invest 1986 1.12
112 A chimpanzee-passaged human immunodeficiency virus isolate is cytopathic for chimpanzee cells but does not induce disease. J Virol 1991 1.12
113 A simian immunodeficiency virus envelope V3 cytotoxic T-lymphocyte epitope in rhesus monkeys and its restricting major histocompatibility complex class I molecule Mamu-A*02. J Virol 1994 1.12
114 JC virus regulatory region tandem repeats in plasma and central nervous system isolates correlate with poor clinical outcome in patients with progressive multifocal leukoencephalopathy. J Virol 2001 1.10
115 A humanized form of a CD4-specific monoclonal antibody exhibits decreased antigenicity and prolonged plasma half-life in rhesus monkeys while retaining its unique biological and antiviral properties. AIDS Res Hum Retroviruses 1997 1.10
116 Lymphoproliferative syndrome in an immunodeficient rhesus monkey naturally infected with an HTLV-III-like virus (STLV-III). Lab Invest 1986 1.09
117 Simian immunodeficiency virus-specific cytotoxic T lymphocytes and cell-associated viral RNA levels in distinct lymphoid compartments of SIVmac-infected rhesus monkeys. Blood 2000 1.09
118 The TCR repertoire of an immunodominant CD8+ T lymphocyte population. J Immunol 2001 1.08
119 The KIR and CD94/NKG2 families of molecules in the rhesus monkey. Immunol Rev 2001 1.07
120 Intestinal stromal tumors in a simian immunodeficiency virus-infected, simian retrovirus-2 negative rhesus macaque (Macaca mulatta). Vet Pathol 2005 1.06
121 In vivo administration to rhesus monkeys of a CD4-specific monoclonal antibody capable of blocking AIDS virus replication. AIDS Res Hum Retroviruses 1993 1.05
122 Simian immunodeficiency virus (SIV)-specific CTL are present in large numbers in livers of SIV-infected rhesus monkeys. J Immunol 2000 1.05
123 HIV-1 env DNA vaccine administered to rhesus monkeys elicits MHC class II-restricted CD4+ T helper cells that secrete IFN-gamma and TNF-alpha. J Immunol 1997 1.05
124 Delineation of lymphocyte subsets in lymph nodes of nonhuman primates. Clin Immunol Immunopathol 1984 1.04
125 IL-15 stimulates the expansion of AIDS virus-specific CTL. J Immunol 1996 1.04
126 Detection of JC virus DNA in peripheral blood cell subpopulations of HIV-1-infected individuals. J Neurovirol 1999 1.04
127 The tempo and mode of SIV quasispecies development in vivo calls for massive viral replication and clearance. Virology 1995 1.04
128 CD8+ cytotoxic T lymphocyte responses to lentiviruses and herpesviruses. Curr Opin Immunol 2001 1.03
129 Clonally diverse CTL response to a dominant viral epitope recognizes potential epitope variants. J Immunol 2001 1.03
130 Unusually limited nucleotide sequence variation of the expressed major histocompatibility complex class I genes of a New World primate species (Saguinus oedipus). Immunogenetics 1991 1.02
131 T lymphocyte immunity to reovirus: cellular requirements for generation and role in clearance of primary infections. J Immunol 1981 1.01
132 Lymphatic tissue changes in AIDS and other retrovirus infections: tools and insights. Lymphology 1990 1.00
133 Loss of Ia-bearing splenic adherent cells after whole body ultraviolet irradiation. J Immunol 1980 0.99
134 Predominant use of a T-cell receptor V beta gene family in simian immunodeficiency virus Gag-specific cytotoxic T lymphocytes in a rhesus monkey. J Virol 1992 0.99
135 Immunologic effects of whole body ultraviolet (UV) irradiation. II. Defect in splenic adherent cell antigen presentation for stimulation of T cell proliferation. J Immunol 1980 0.98
136 Vaccination of mice and nonhuman primates using HIV-gene-containing DNA. Antibiot Chemother (1971) 1996 0.98
137 In vivo administration of CD4-specific monoclonal antibody: effect on provirus load in rhesus monkeys chronically infected with the simian immunodeficiency virus of macaques. AIDS Res Hum Retroviruses 1995 0.98
138 Experimental infection of rhesus monkeys with type D retrovirus. J Virol 1984 0.98
139 An activated CD8+ lymphocyte appears in lymph nodes of rhesus monkeys early after infection with simian immunodeficiency virus. J Clin Invest 1991 0.98
140 Clinical and pathologic features of an acquired immune deficiency syndrome (AIDS) in macaque monkeys. Adv Vet Sci Comp Med 1984 0.98
141 Equivalent induction of telomerase-specific cytotoxic T lymphocytes from tumor-bearing patients and healthy individuals. Cancer Res 2001 0.97
142 The T cell receptor gene usage by simian immunodeficiency virus gag-specific cytotoxic T lymphocytes in rhesus monkeys. J Immunol 1996 0.97
143 Role of CD26/dipeptidyl peptidase IV in human immunodeficiency virus type 1 infection and apoptosis. Proc Natl Acad Sci U S A 1994 0.97
144 Down-regulation of macaque gammadelta + T cells in lymphoid compartments after rectal infection with SIVsmmPBj14. J Med Primatol 2000 0.96
145 Induction of antibodies in guinea pigs and rhesus monkeys against the human immunodeficiency virus type 1 envelope: neutralization of nonpathogenic and pathogenic primary isolate simian/human immunodeficiency virus strains. J Virol 2000 0.96
146 Simian immunodeficiency virus-specific cytotoxic T lymphocytes are present in the AIDS-associated skin rash in rhesus monkeys. J Immunol 1992 0.96
147 Retrovirus D/New England and its relation to Mason-Pfizer monkey virus. J Virol 1985 0.95
148 Surface antigen changes during B-lymphocyte activation in primates. Cell Immunol 1984 0.95
149 Simian models for AIDS. Cancer Detect Prev Suppl 1987 0.95
150 In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates: I. Effects of anti-T11 antibodies on the circulating T cell pool. Blood 1985 0.95
151 A commonly recognized simian immunodeficiency virus Nef epitope presented to cytotoxic T lymphocytes of Indian-origin rhesus monkeys by the prevalent major histocompatibility complex class I allele Mamu-A*02. J Virol 2001 0.94
152 Soluble human CD4 elicits an antibody response in rhesus monkeys that inhibits simian immunodeficiency virus replication. Proc Natl Acad Sci U S A 1991 0.93
153 Effect of complement consumption by cobra venom factor on the course of primary infection with simian immunodeficiency virus in rhesus monkeys. AIDS Res Hum Retroviruses 1999 0.93
154 Immunoglobulin V(H) usage during primary infection of rhesus monkeys with chimeric simian-human immunodeficiency viruses. J Virol 1997 0.93
155 Human immunodeficiency virus type 1 envelope epitope-specific CD4(+) T lymphocytes in simian/human immunodeficiency virus-infected and vaccinated rhesus monkeys detected using a peptide-major histocompatibility complex class II tetramer. J Virol 2000 0.93
156 Studies of complement-activating antibodies in the SIV/macaque model of acute primary infection and vaccine protection. AIDS Res Hum Retroviruses 1995 0.92
157 Common tree shrews and primates share leukocyte membrane antigens. J Med Primatol 1984 0.92
158 Prolongation of primate renal allograft survival by anti-Tac, an anti-human IL-2 receptor monoclonal antibody. Transplantation 1989 0.92
159 A primate species with limited major histocompatibility complex class I polymorphism. Proc Natl Acad Sci U S A 1988 0.92
160 In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. Delivery of ribosome-inactivating proteins to spleen and lymph node T cells. J Clin Invest 1986 0.92
161 Influence of cell cycle phase-specific agents on simian fetal hemoglobin synthesis. J Clin Invest 1985 0.91
162 Lyt-1 cells mediate acute murine experimental allergic encephalomyelitis. J Immunol 1984 0.91
163 In vivo T-lymphocyte activation and transient reduction of viral replication in macaques infected with simian immunodeficiency virus. J Virol 2001 0.91
164 Regions of the CD4 molecule not involved in virus binding or syncytia formation are required for HIV-1 infection of lymphocytes. J Immunol 1992 0.91
165 Monoclonal anti-IL-2 receptor antibody in primate renal transplantation. Transplant Proc 1987 0.90
166 Anti-HIV env immunities elicited by nucleic acid vaccines. Vaccine 1997 0.90
167 Administration of recombinant human interleukin 12 to chronically SIVmac-infected rhesus monkeys. AIDS Res Hum Retroviruses 1998 0.90
168 Characterization of rhesus monkey CD94/NKG2 family members and identification of novel transmembrane-deleted forms of NKG2-A, B, C, and D. Immunogenetics 2000 0.89
169 Immunization of simian immunodeficiency virus-infected rhesus monkeys with soluble human CD4 elicits an antiviral response. Proc Natl Acad Sci U S A 1991 0.89
170 An acutely lethal simian immunodeficiency virus stimulates expansion of V beta 7- and V beta 14-expressing T lymphocytes. Proc Natl Acad Sci U S A 1994 0.89
171 Prevention of experimental allergic encephalomyelitis (EAE) in the SJL/J mouse by whole body ultraviolet irradiation. J Immunol 1984 0.89
172 Germline repertoire of the immunoglobulin V(H)3 family in rhesus monkeys. Immunogenetics 2000 0.89
173 Sequence and diversity of rhesus monkey T-cell receptor beta chain genes. Immunogenetics 1992 0.89
174 Origins of HTLV-4. Nature 1987 0.89
175 Experimental allergic encephalomyelitis in cynomolgus monkeys. Quantitation of T cell responses in peripheral blood. J Clin Invest 1992 0.88
176 Functional equivalency of B7-1 and B7-2 for costimulating plasmid DNA vaccine-elicited CTL responses. J Immunol 2000 0.88
177 Development of a monoclonal antibody, anti-6C2, which is involved in the interaction of CD4 T helper cells and activated B cells. J Immunol 1991 0.87
178 Alterations in T cell phenotype and human immunodeficiency virus type 1-specific cytotoxicity after potent antiretroviral therapy. J Infect Dis 2001 0.87
179 What immunity can protect against HIV infection. J Clin Invest 1998 0.87
180 In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. V. Evidence that humoral immune response to monoclonal antibodies and immunotoxin conjugates abrogates their cytotoxic activity. Transplantation 1989 0.87
181 HIV-1 envelope-specific CD4+ T helper cells from simian/human immunodeficiency virus-infected rhesus monkeys recognize epitopes restricted by MHC class II DRB1*0406 and DRB*W201 molecules. J Immunol 1997 0.87
182 CD4-Pseudomonas exotoxin conjugates delay but do not fully inhibit human immunodeficiency virus replication in lymphocytes in vitro. J Clin Invest 1990 0.86
183 A human recombinant Fab identifies a human immunodeficiency virus type 1-induced conformational change in cell surface-expressed CD4. J Virol 1995 0.86
184 Biochemical and molecular characterization of rhesus monkey major histocompatibility complex class II DR. Hum Immunol 1995 0.86
185 Simian immunodeficiency virus induces expression of class II major histocompatibility complex structures on infected target cells in vitro. J Virol 1987 0.86
186 An adherent cell lyses virus-infected targets: characterization, activation, and fine specificity of the cytotoxic cell. J Immunol 1982 0.86
187 Report of a false-positive HIV test result and the potential use of additional tests in establishing HIV serostatus. Arch Intern Med 2000 0.86
188 Variable NKG2 expression in the peripheral blood lymphocytes of rhesus monkeys. Clin Exp Immunol 2004 0.85
189 Risks of handling HIV. Nature 1991 0.85
190 Chimpanzees immunized with recombinant soluble CD4 develop anti-self CD4 antibody responses with anti-human immunodeficiency virus activity. Proc Natl Acad Sci U S A 1992 0.85
191 Infection of baboons with human immunodeficiency virus-2 (HIV-2) J Infect Dis 1987 0.84
192 Definition of the T-lymphocyte inducer of suppression in primates using a monoclonal antibody. Cell Immunol 1985 0.83
193 A naturally occurring bone marrow-chimeric primate. II. Environment dictates restriction on cytolytic T lymphocyte-target cell interactions. J Exp Med 1985 0.83
194 Genetically distinct cell populations in naturally occurring bone marrow-chimeric primates express similar MHC class I gene products. J Immunol 1990 0.83
195 DNA vaccination for HIV-1 and SIV. Intervirology 2000 0.83
196 Detection of simian immunodeficiency virus and human immunodeficiency virus type 2 capsid antigens by a monoclonal antibody-based antigen capture assay. AIDS Res Hum Retroviruses 1993 0.83
197 Airway CD8(+) T cells induced by pulmonary DNA immunization mediate protective anti-viral immunity. Mucosal Immunol 2012 0.82
198 Segmental exchange between MHC class I genes in a higher primate: recombination in the gorilla between the ancestor of a human non-functional gene and an A locus gene. Immunogenetics 1991 0.82
199 Plaque-forming cell responses to trinitrophenyl (TNP)-L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT) in microcultures are not under conventional Ir gene control. J Immunol 1981 0.82
200 Disseminated granulomatous disease in a simian immunodeficiency virus- and bacille Calmette-Guèrin-infected rhesus monkey. AIDS 1997 0.82
201 An IL-2/Ig fusion protein influences CD4+ T lymphocytes in naive and simian immunodeficiency virus-infected Rhesus monkeys. AIDS Res Hum Retroviruses 2001 0.82
202 Macaque monkey type D retrovirus replicates in vitro in a distinct subpopulation of B lymphocytes. J Gen Virol 1987 0.82
203 Molecular cloning of cDNA that encode MHC class I molecules from a New World primate (Saguinus oedipus). Natural selection acts at positions that may affect peptide presentation to T cells. J Immunol 1990 0.81
204 Herpesvirus ateles immortalizes in vitro a CD3+CD4+CD8+ marmoset lymphocyte with NK function. J Immunol 1988 0.80
205 Immunization with lentivirus-like particles elicits a potent SIV-specific recall cytotoxic T-lymphocyte response in rhesus monkeys. AIDS Res Hum Retroviruses 1993 0.80
206 B-lymphocyte responses to trinitrophenyl-ficoll. II. Decreased splenic adherent cell function in mice expressing the xid gene. Cell Immunol 1982 0.80
207 Prolonged dominance of clonally restricted CD4(+) T cells in macaques infected with simian immunodeficiency viruses. J Virol 2000 0.79
208 Detection of simian immunodeficiency virus Gag-specific CD8(+) T lymphocytes in semen of chronically infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex. J Virol 1999 0.79
209 Prolongation of primate renal allografts with anti-Tac monoclonal antibody. Curr Surg 1988 0.79
210 Two more chimpanzee Patr-A locus alleles related to the HLA-A1/A3/A11 family. Immunogenetics 1993 0.79
211 Detection of apoptotic cells from peripheral blood of HIV-infected individuals using a novel monoclonal antibody. AIDS 1997 0.79
212 Cytokine-induced augmentation of DNA vaccine-elicited SIV-specific immunity in rhesus monkeys. Dev Biol (Basel) 2000 0.78
213 Use of an animal model for the study of the role of human immunodeficiency virus 1 in the human intestine. Gastroenterology 1992 0.78
214 Substitutions in a major histocompatibility complex class II-restricted human immunodeficiency virus type 1 gp120 epitope can affect CD4+ T-helper-cell function. J Virol 1998 0.78
215 Systemic vaccination induces clonally diverse SIV-specific CD8+ T-cell populations in systemic and mucosal compartments. Mucosal Immunol 2012 0.78
216 Isoelectric focusing of bovine major histocompatibility complex class II molecules. Eur J Immunol 1989 0.78
217 Role of the 2H4 molecule in the activation of suppressor inducer function. Eur J Immunol 1988 0.78
218 DNA vaccines. AIDS Res Hum Retroviruses 1996 0.78
219 Inhibition of allergic encephalomyelitis in marmosets by vaccination with recombinant vaccinia virus encoding for myelin basic protein. J Neuroimmunol 1997 0.78
220 Immunologic effects of whole-body ultraviolet (uv) irradiation. III Defective splenic adherent cell function in alloantigen-stimulated T-cell proliferation. Cell Immunol 1981 0.78
221 Hematogenous hexamitiasis in a macaque monkey with an immunodeficiency syndrome. J Infect Dis 1984 0.78
222 HIV epitopes recognized by cytotoxic T-lymphocytes. AIDS 1991 0.78
223 B7 co-stimulatory requirements differ for induction of immune responses by DNA, protein and recombinant pox virus vaccination. Eur J Immunol 2000 0.77
224 The repertoire of cytotoxic T lymphocytes in the recognition of mutant simian immunodeficiency virus variants. J Immunol 1994 0.77
225 Use of cDNA probes specific for the human MHC class II beta loci for tissue-typing nonhuman primates at their class II beta loci. Transplantation 1989 0.77
226 Virus-specific cytotoxic T lymphocytes in human immunodeficiency virus type 1-infected chimpanzees. J Virol 1999 0.77
227 Evaluation of a lipopeptide immunogen as a therapeutic in HIV type 1-seropositive individuals. AIDS Res Hum Retroviruses 2000 0.77
228 Limited MHC class I polymorphism is not essential for bone marrow chimerism in New World primates. Immunogenetics 1991 0.77
229 Animal models of AIDS. Semin Oncol 1984 0.76
230 Sequence and evolution of cattle MHC class I cDNAs: concerted evolution has not taken place in cattle. Immunogenetics 1993 0.76
231 Lymphomatoid papulosis and human herpesviruses--A PCR-based evaluation for the presence of human herpesvirus 6, 7 and 8 related herpesviruses. J Cutan Pathol 2001 0.76
232 In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. IV. Cytotoxic effect of an anti-T11-gelonin immunotoxin. J Clin Invest 1988 0.76
233 MHC expression of African green monkeys of Barbados is limited in heterogeneity. J Med Primatol 1995 0.75
234 Anti-TAC MOAB prolongs renal allografts in cynomolgus monkeys. Transplant Proc 1989 0.75
235 The genetic restriction of T lymphocyte-B lymphocyte interactions. An overview. Surv Immunol Res 1982 0.75
236 Isoelectric focusing of bovine major histocompatibility complex class I molecules. J Immunogenet 1989 0.75
237 Clinicopathological characterization of an HIV-2-infected individual with two clonally unrelated primary lymphomas. Am J Hematol 2000 0.75
238 Antibody responses to trinitrophenyl (TNP)-L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT) in microcultures: anti-hapten and anti-carrier responses appear to be under separable control. Cell Immunol 1982 0.75
239 A vaccine that delivers rather than induces antibodies. Gene Ther 2009 0.75
240 Development of large granular lymphocytes in owl monkeys following EBV inoculation. J Infect Dis 1985 0.75
241 An acquired immune deficiency syndrome of macaque monkeys. Ann N Y Acad Sci 1984 0.75
242 Use of radiolabeled monoclonal anti-B1 antibody for B lymphocyte imaging in rhesus monkeys. Int J Rad Appl Instrum B 1987 0.75
243 Postbinding functions of CD4 in HIV infection. Trends Microbiol 1996 0.75
244 Detection of viral RNA in CD4(-)CD8(-) and CD4(-)CD8(+) lymphocytes in vivo in rhesus monkeys infected with simian immunodeficiency virus of macaques. AIDS Res Hum Retroviruses 2001 0.75